No black box warning on record for Norditropin

As of the latest FDA labeling reviewed, Norditropin (SOMATROPIN) does not carry a black box warning. Standard warnings and precautions still apply — see the full Norditropin medicine page for the complete safety profile.

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Increased Risk of Neoplasms : Second neoplasms have occurred in childhood cancer survivors. Monitor patients with preexisting tumors for progression or recurrence. ( 5.3 ) • Glucose Intolerance and Diabetes Mellitus : NORDITROPIN may decrease insulin sensitivity, particularly at higher doses. Monitor glucose levels periodically in all patients receiving NORDITROPIN, es

No black box warning on record for Norditropin

Other warnings & precautions

5 WARNINGS AND PRECAUTIONS • Increased Risk of Neoplasms : Second neoplasms have occurred in childhood cancer survivors. Monitor patients with preexisting tumors for progression or recurrence. ( 5.3 ) • Glucose Intolerance and Diabetes Mellitus : NORDITROPIN may decrease insulin sensitivity, particularly at higher doses. Monitor glucose levels periodically in all patients receiving NORDITROPIN, es

Norditropin Black Box Warning

No black box warning on record for Norditropin

Other warnings & precautions

Norditropin Black Box Warning

No black box warning on record for Norditropin

Other warnings & precautions